Vaneck Vectors Pharmaceutical etf shares owned by Oppenheimer & Co
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Oppenheimer & Co
from 13F filings
Historical chart of Oppenheimer & Co investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Oppenheimer & Co consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Oppenheimer & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $926k | 10k | 90.36 |
| 2025-06-30 | $977k | 11k | 87.96 |
| 2025-03-31 | $992k | 11k | 91.13 |
| 2024-12-31 | $1.1M | 13k | 86.28 |
| 2024-09-30 | $1.3M | 13k | 95.03 |
| 2024-03-31 | $1.2M | 14k | 90.70 |
| 2023-09-30 | $703k | 8.8k | 79.86 |
| 2023-06-30 | $2.3M | 29k | 78.77 |
| 2023-03-31 | $3.5M | 45k | 77.63 |
| 2022-12-31 | $3.6M | 46k | 77.74 |
| 2022-09-30 | $3.3M | 49k | 67.24 |
| 2022-06-30 | $2.5M | 33k | 76.83 |
| 2022-03-31 | $1.0M | 13k | 79.76 |
| 2021-12-31 | $790k | 10k | 76.97 |
| 2021-09-30 | $749k | 10k | 72.88 |
| 2021-06-30 | $697k | 9.5k | 73.10 |
| 2021-03-31 | $555k | 8.0k | 69.03 |
| 2020-12-31 | $601k | 9.0k | 66.48 |
| 2020-09-30 | $562k | 9.0k | 62.17 |
| 2020-06-30 | $563k | 9.0k | 62.28 |
| 2020-03-31 | $583k | 11k | 54.28 |
| 2019-12-31 | $713k | 11k | 64.22 |
| 2019-09-30 | $643k | 11k | 57.03 |
| 2019-06-30 | $784k | 13k | 58.67 |
| 2019-03-31 | $830k | 14k | 60.74 |
| 2018-12-31 | $754k | 14k | 54.78 |
| 2018-09-30 | $880k | 14k | 64.33 |
| 2018-06-30 | $787k | 13k | 59.04 |
| 2018-03-31 | $758k | 13k | 56.83 |
| 2017-12-31 | $791k | 13k | 59.30 |
| 2017-09-30 | $772k | 13k | 57.79 |
| 2017-06-30 | $796k | 14k | 59.01 |
| 2017-03-31 | $745k | 14k | 55.10 |
| 2016-12-31 | $1.1M | 20k | 52.52 |
| 2016-09-30 | $953k | 17k | 57.46 |
| 2016-06-30 | $973k | 17k | 58.63 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf